The financing, led by new investor Foresite Capital, will help DNAnexus deploy its genome informatics technology and expand its clinical trials presence.
DNAnexus is running a pilot on its genome informatics platform with Google's newly open-sourced DeepVariant variant calling tool.
Under the partnership, DNAnexus customers will have direct access to the Dragen Genome Pipeline for "ultra-rapid" genome analysis.
Vendors DNAnexus and Saphetor hope to create a seamless platform for genome-based biomarker discovery and interpretation.
The AstraZeneca Centre for Genomics Research has tapped DNAnexus to develop a secure genomics informatics environment for analyzing 2 million genomes.
DNAnexus customers now have a choice of two cloud platforms and ancillary tools and the company has access to a wider pool of potential users.
Researchers participating in ORIEN's Avatar program can use the platform to manage, share, integrate, and analyze molecular data from consenting patients.
The current arrangement builds on an existing agreement signed last year that allowed Garvan to use DNAnexus' platform for its genomics activities.
The WGS service will be provided by Genome.One, a new health information company owned by and based at the Garvan Institute of Medical Research in Sydney.
The combined solution gives customers access to the bioinformatics tools and genomic intelligence to help them analyze data and make business decisions.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.